Company: PFSA
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001213900-25-112723
Chunk: 182

Company: Profusa, Inc.
Filing Date: 2025-11-19
Form: 10-Q
Item: Part I, Item 8
Chunk 182
---
 convertible debt 
     258  
     (319)
  
    Gain on change in the fair value of warrant liabilities 
     884  
     - 
  
    Loss on change in the fair value of digital assets 
     (28) 
     - 
  
    Interest expense 
     (169) 
     (1,073)
  
    Financing costs 
     (1.443) 
     - 
  
    Other income (loss) 
     15  
     (1)
  
    Total other expense, net 
     (484) 
     (1,394)
  
    Net loss and comprehensive loss 
     (22,192) 
     (2,497)

(1)Other
expenses includes small balances of research materials and supplies along with insurance costs and other third party service providers.

    Nine Months Ended September 30, 

    2025  
    2024 
  
    Government grant revenue 
    $-  
    $100 
  
    Operating expenses: 

    Research personnel compensation costs, including stock-based compensation 
     945  
     1,198 
  
    CRO and regulatory costs 
     315  
     15 
  
    Administrative personnel compensation costs, including stock-based compensation 
     4,861  
     1,014 
  
    Rent and office costs 
     415  
     196 
  
    Legal and accounting costs 
     1,625  
     1,018 
  
    Transaction costs 
     15,060  
     - 

    Other expenses(1) 
     915  
     77 
  
    Total segment expenses 
     24,136  
     3,518 
  
    Loss from operations 
     (24,136) 
     (3,418)
  
    Other income (expense) 

    (Loss) on change in the fair value of related party convertible debt 
     (52) 
     (427)
  
    Gain on change in the fair value of warrant liabilities 
     884  
     - 
  
    Loss on change in the fair value of digital assets 
     (28) 
     - 
  
    Interest expense 
     (2,496) 
     (3,138)
  
    Financing costs 
     (1,443)